-
Mashup Score: 2Burgess To Becerra: Site Neutral Policies Can Replace Budget Neutrality | InsideHealthPolicy.com - 25 day(s) ago
Rep. Michael Burgess (R-TX) told HHS Secretary Xavier Becerra that implementing uniform payments for health care services across all settings, whether in a physician’s office or a hospital, could eliminate the need for other financial offsets typically required by budget neutrality, which mandates any new spending or policy change cannot increase the federal deficit.
Source: insidehealthpolicy.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 1Congress Passes CR Without Doc Fix Despite Doctors Caucus Efforts | InsideHealthPolicy.com - 4 month(s) ago
Several sources tell Inside Health Policy that the GOP Doctors Caucus came close to getting a “doc fix” averting Medicare physician pay cuts into the latest continuing resolution (CR), but the CR now heads to President Joe Biden’s desk without the fix, to the dismay of physicians who will continue to urge lawmakers to stop the cuts.
Source: insidehealthpolicy.comCategories: General Medicine News, Future of MedicineTweet-
RT @InHealthPolicy: Congress Passes CR Without Doc Fix Despite Doctors Caucus Efforts https://t.co/4mSGLnd7SB
-
-
Mashup Score: 0InsideHealthPolicy.com | An Inside Washington news service - 9 month(s) ago
InsideHealthPolicy is a subscription-based news service on the evolving debate over federal health-care policy reforms and spending.
Source: insidehealthpolicy.comCategories: Future of Medicine, Latest HeadlinesTweet-
AI Flourishes Amid Dry Up In Digital #HealthTech | https://t.co/Z4IvtR1AVi https://t.co/sHHPRUPxh7 https://t.co/9M5F67I1sX
-
-
Mashup Score: 1E&C Panel Passes Site-Neutral Pay For Rx Administration, McMorris Rodgers Says More Coming | InsideHealthPolicy.com - 1 year(s) ago
House Energy & Commerce Chair Cathy McMorris Rodgers (R-WA) ultimately pulled a Medicare site-neutral pay expansion amendment from consideration during the health subcommittee’s Wednesday (May 17) markup of wide-ranging health legislation, saying the committee had more work to do on the policies — but she implored hospitals to work with lawmakers as she said Medicare should
Source: insidehealthpolicy.comCategories: Future of Medicine, Latest HeadlinesTweet-
RT @InHealthPolicy: E&C Panel Passes Site-Neutral Pay For Rx Administration, McMorris Rodgers Says More Coming https://t.co/i8An1PlNfn
-
-
Mashup Score: 0Becerra Lashes Out At Industry For ‘Categorially False’ Claims CMS Will Cut MA | InsideHealthPolicy.com - 1 year(s) ago
HHS Secretary Xavier Becerra called any claim that CMS is proposing to cut Medicare Advantage pay for 2024 “categorically false,” as he hit back at those he dubbed “industry hacks and their allies” and doubled down on CMS’ projection that the advance notice of MA pay rates would lead plans to see about a 1% pay bump for next year.
Source: insidehealthpolicy.comCategories: Latest Headlines, PayerTweet-
signaling internal support for CMS, "@SecBecerra hit back at those he dubbed “industry hacks and their allies” and doubled down on CMS’ projection that the advance notice of MA pay rates would lead plans to see about a 1% pay bump for next year" https://t.co/4nybmE4T02
-
-
Mashup Score: 1Bipartisan Pediatric Cancer Drug Research Bill Left Out Of Year-End Package | InsideHealthPolicy.com - 1 year(s) ago
A bipartisan bill that aimed to give FDA authority to require sponsors of pediatric cancer trials study a combination of drugs, rather than one drug at a time, in order to speed development of drugs that treat relapsed cancer did not make it into the year-end spending package.
Source: insidehealthpolicy.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @InHealthPolicy: Bipartisan Pediatric Cancer Drug Research Bill Left Out Of Year-End Package https://t.co/HCTl5khaCQ
-
-
Mashup Score: 0Gottlieb: Congress Should Regulate LDTs, LDT Community Should Rethink Marketing | InsideHealthPolicy.com - 2 year(s) ago
FDA Commissioner Scott Gottlieb said that Congress should legislatively lay out the government’s role in overseeing diagnostic tests, and that the broader diagnostic testing community should work together to understand how to commercialize tests so they better benefit patients.
Source: insidehealthpolicy.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
Background: When I was FDA commissioner, the agency delivered to Congress comprehensive technical assistance on which VALID is based; as I discussed at Friends of Cancer Research in 2017: https://t.co/s1lMo7i7Ij I wrote this as well when VALID was introduced in March 2020. 2/x https://t.co/VowYUszJVh
-
-
Mashup Score: 10Cavazzoni: FDA May Loosen Advisory Committee Conflict Of Interest Rules | InsideHealthPolicy.com - 3 year(s) ago
FDA drug center Director Patrizia Cavazzoni told members of the Biotechnology Innovation Organization that the agency wants to rethink its advisory committee processes, including loosening up conflict of interest rules and removing “some of the emotional” undertones that have been present in recent committee meetings. The agency looks forward to receiving feedback from industry, she said….
Source: insidehealthpolicy.comCategories: Latest Headlines, PayerTweet-
For those of us worried about regulatory capture, this story by @bawang about FDA's CDER director is setting off alarm bells ... "emotional undertones or overtones"? "very hard facts to the contrary"? @gregggonsalves @akesselheim @cmorten2 https://t.co/vmk2MveNac https://t.co/zQMvAW9oR9
-
-
Mashup Score: 20Home | InsideHealthPolicy.com - 3 year(s) ago
Rep. John Larson (D-CT) is gathering lawmakers to support his request, backed by durable medical equipment suppliers, that CMS keep manual rehab technology out of competitive bidding after the end of the month, when an exemption for those accessories is set to expire. Public Citizen has asked HHS Secretary Xavier Becerra to remove or request resignations from acting…
Source: insidehealthpolicy.comCategories: HIV/AIDS, Latest HeadlinesTweet-
OMG. @FDACDERDirector is the proverbial fox loose in the henhouse. What kind of fuckery is this from her and her patron @DrWoodcockFDA. Cavazzoni: FDA May Loosen Advisory Committee Conflict Of Interest Rules | https://t.co/3dRYTo2k3I 1/ https://t.co/WQ1nUrzXrI
-
-
Mashup Score: 0Home | InsideHealthPolicy.com - 3 year(s) ago
FDA-regulated industry, consumer advocacy groups and former FDA chiefs say a new HHS rule that requires health agency regulations be assessed every 10 years or be automatically scrapped is a waste of FDA resources. In another 11th-hour move, the Trump CMS finalized Tuesday (Jan. 12) a rule, long-sought by the…
Source: insidehealthpolicy.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Lilly, AstraZeneca, Sanofi Sue HHS Over 340B Contract Pharmacy Opinion | https://t.co/4Hfwapw0FT Will be interesting to see how this plays out. #340B discounts should go directly to patients in need, not hospitals. 340B bubble bursting? https://t.co/77zBt9jMLT
-
RT @InHealthPolicy: Burgess To Becerra: Site Neutral Policies Can Replace Budget Neutrality https://t.co/tMvRvMYdRJ